Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA
Alexander H. Yang, Monica A. Tincopa, Federica Tavaglione, et al.
Gut (2024) Vol. 73, Iss. 12, pp. 2045-2053
Open Access | Times Cited: 9

Showing 9 citing articles:

Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study
Federica Tavaglione, Maral Amangurbanova, Alexander H. Yang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 8
Steatotic Liver Disease Prevalence in China: A Population‐Based Study and Meta‐Analysis of 17.4 Million Individuals
Zhenqiu Liu, Jiayi Huang, Luojia Dai, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors
Francisco Capinha, Sofia Carvalhana, Helena Cortez‐Pinto
Digestive Diseases and Sciences (2025)
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease Induced by Microplastics: An Endpoint in the Liver–Eye Axis
Ivan Šoša, Loredana Labinac, Manuela Perković
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2837-2837
Open Access
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021
Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Liver International (2025) Vol. 45, Iss. 3
Open Access
Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol—Authors' Reply
Federica Tavaglione, Rohit Loomba
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Letter on ‘Head‐To‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study’ Authors' Reply
Federica Tavaglione, Rohit Loomba
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Editorial: Balancing the Yin and Yang of Alcohol‐Associated Liver Disease—Integrating Pathophysiology, Liver‐Directed Therapy, and Addiction Management. Authors' Reply
Luis Antonio Díaz, Rohit Loomba
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Díaz, Juan Pablo Arab, Francisco Idalsoaga, et al.
Annals of Hepatology (2025), pp. 101903-101903
Open Access
Page 1

Scroll to top